Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Schizophrenia: pathophysiological mechanisms--a synthesis.

L Terenius1

  • 1Department of Clinical Neuroscience, Experimental Alcohol and Drug Addiction Research, CMM L8:01, Karolinska Hospital, S-171 76, Stockholm, Sweden.

Brain Research. Brain Research Reviews
|March 17, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GPR37 and GPR37L1 differently interact with dopamine 2 receptors in live cells.

Neuropharmacology·2018
Same author

Prolonged receptor blockade by opioid receptor probes.

Pharmaceutical research·2013
Same author

Common variant at 16p11.2 conferring risk of psychosis.

Molecular psychiatry·2012
Same author

The role of genetics in promoting suicide prevention and the mental health of the population. Preface.

European psychiatry : the journal of the Association of European Psychiatrists·2010
Same author

Intracisternal administration of cholecystokinin-8 counteracts the central cardiovascular effects of adrenaline and NPY. A study based on the coexistence of cholecystokinin, phenylethanolamine N-methyltransferase and neuropeptide Y immunoreactivity in neurons of the nucleus tractus solitarius.

Neurochemistry international·2010
Same author

Studies on neuropeptide Y-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Relationship to neuroendocrine function.

Neurochemistry international·2010

Schizophrenia research faces complexity due to vast data and lack of a unifying model. Advances in molecular pathology and imaging require better data integration for understanding disease mechanisms and developing targeted therapies.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • The Nobel Symposium on Schizophrenia: Pathophysiological Mechanisms convened in 1998.
  • Schizophrenia research encompasses etiology, genetics, neuropathology, neurotransmitters, and brain imaging.
  • The field faces an enormous and rapidly growing body of information.

Purpose of the Study:

  • To review current knowledge on schizophrenia's pathophysiological mechanisms.
  • To highlight the complexity and challenges in modeling schizophrenia.
  • To identify needs for future research directions and therapeutic development.

Main Methods:

  • The symposium covered diverse research areas including genetics, neurobiology, and advanced imaging techniques.
  • Discussion involved integrating findings from molecular pathology and gene transcript profiling.

Related Experiment Videos

  • Focus shifted towards complex interactive models over simplistic ones.

    • Main Results:

    • The complexity of schizophrenia is underscored by the absence of a comprehensive disease model.
    • Significant advancements in non-invasive imaging and molecular techniques are rapidly expanding data.
    • There is a recognized need for improved data storage and retrieval systems.

    Conclusions:

    • Understanding schizophrenia requires moving towards more complex, interactive models.
    • Enhanced data management is crucial for integrating diverse research findings.
    • Future therapeutic efficacy may improve through rational drug design and stochastic chemical library searches.